Evoke Pharma
Patents, Design & Utilities

Last updated:

List of all Evoke Pharma patents 9 in total

Status Patent
Application
Utility: TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESIS External link
Filling date: 7 Sep 2025 Issue date: 19 May 2022
Application
Utility: NASAL FORMULATIONS OF METOCLOPRAMIDE External link
Filling date: 7 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: NASAL FORMULATIONS OF METOCLOPRAMIDE External link
Filling date: 7 Sep 2025 Issue date: 28 Oct 2021
Application
Utility: NASAL FORMULATIONS OF METOCLOPRAMIDE External link
Filling date: 7 Sep 2025 Issue date: 28 Oct 2021
Application
Utility: NASAL FORMULATIONS OF METOCLOPRAMIDE External link
Filling date: 7 Sep 2025 Issue date: 1 Apr 2021
Application
Utility: TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESIS External link
Filling date: 7 Sep 2025 Issue date: 31 Dec 2020
Application
Utility: METHODS OF INTRANASAL METOCLOPRAMIDE DOSING External link
Filling date: 7 Sep 2025 Issue date: 3 Sep 2020
Application
Utility: TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESIS External link
Filling date: 7 Sep 2025 Issue date: 26 Dec 2019
Application
Utility: TREATMENT OF MODERATE AND SEVERE GASTROPARESIS External link
Filling date: 7 Sep 2025 Issue date: 31 Oct 2019

Showing 1 to 9 of 9 patents.